WorldWideScience

Sample records for endoxan

  1. Combined effects of a chemical mutagen and radiation sterilized diet in mutagenicity and reproduction studies in the same mouse

    International Nuclear Information System (INIS)

    Renner, H.W.

    1975-01-01

    The possible intensification of the mutagenic effect of cyclophosphamide (Endoxan) by the feeding of a radiation-sterilized diet (dose, 4.5 Mrad) was studied in 2000 NMRI/Han mice. In a dominant lethal test, males were pretreated with 100 mg Endoxan/kg body weight. The greatest sensitivity towards Endoxan was observed during the late-spermatid stage. No significant differences were detected between the control group (Endoxan plus non-irradiated diet) and the experimental group (Endoxan plus radiation-sterilized diet). In this test, radiation-sterilized feed showed no co-mutagenic effect when combined with Endoxan treatment. In a reproduction study of 7 months duration (continuous mating without lactation periods), the females were treated every 2 wk with 20 mg Endoxan/kg body weight. The decline in litter size with increasing number of litters (i.e. with advancing age of the females) was more pronounced after treatment with the chemical mutagen than in the untreated group. Increases in the frequency of abortions and in premature sterility resulted from Endoxan treatment. During the entire observation period, no effects from the intake of radiation-sterilized food were detected. (author)

  2. Cell cycle analyses with a pulse cytophotometer: the effect of chemical and physical noxae on the kinetics of the proliferation of tumor cells

    International Nuclear Information System (INIS)

    Goehde, W.

    The following studies were conducted on Ehrlich ascites tumor cells using the pulse cytophotometer: rate of DNA synthesis during the S phase; the effect of cytostatic drugs, endoxan, bleomycin, and other antibiotics on cell kinetics; and effects of x radiation and 1 to 6 MeV neutrons on cell kinetics

  3. Muscular visualisation on a bone scan in paraneoplastic ...

    African Journals Online (AJOL)

    Immunosuppressive therapy based on oral prednisone and endoxan followed by molecular targeted therapy (Herceptin and taxotere) improved the myositis and cutaneous eruption. Tree months later, creatine kinase level and muscular uptake of 99mTc-MDP dramatically decreased (B). Pan African Medical Journal 2016; ...

  4. Influence of chemical inhibitors on cell recovery after exposure to different LET radiation

    Energy Technology Data Exchange (ETDEWEB)

    Evstratova, Ekaterina S.; Petin, Vladislav G. [Medical Radiological Research Center, Obninsk (Russian Federation); Kim, Jin Kyu; KIm, Jin Hong [Korea Atomic Energy Research Institute, Jeongeup (Korea, Republic of)

    2016-12-15

    Chemical radiosensitizers are often used to increase cell radiosensitivity. It is known that the ability of chemical drugs to increase cell radiosensitivity is related with inhibition of cell recovery from damage induced by ionizing radiation. However, there are little comparative investigations of cell sensitivity modification after exposure to radiation with high linear energy transfer (LET). Therefore, we studied the anticancer drugs cisplatin and endoxan and their impact on the ability of yeast cells to recover after cell exposure to radiations with different LET. The ability of cell recovery from radiation damage was less effective after exposure to high-LET radiation, when cells were irradiated without drug, with the increase in cisplatin concentration resulting in the disappearance of this difference. The increase of cisplatin concentration results in progressive increase in the fraction of irreversible damage independently of radiation quality.

  5. Influence of chemical inhibitors on cell recovery after exposure to different LET radiation

    International Nuclear Information System (INIS)

    Evstratova, Ekaterina S.; Petin, Vladislav G.; Kim, Jin Kyu; KIm, Jin Hong

    2016-01-01

    Chemical radiosensitizers are often used to increase cell radiosensitivity. It is known that the ability of chemical drugs to increase cell radiosensitivity is related with inhibition of cell recovery from damage induced by ionizing radiation. However, there are little comparative investigations of cell sensitivity modification after exposure to radiation with high linear energy transfer (LET). Therefore, we studied the anticancer drugs cisplatin and endoxan and their impact on the ability of yeast cells to recover after cell exposure to radiations with different LET. The ability of cell recovery from radiation damage was less effective after exposure to high-LET radiation, when cells were irradiated without drug, with the increase in cisplatin concentration resulting in the disappearance of this difference. The increase of cisplatin concentration results in progressive increase in the fraction of irreversible damage independently of radiation quality.

  6. Primary Adenocarcinoma of the fallopian tube: Case Report

    Directory of Open Access Journals (Sweden)

    Mert Kazandi

    2010-10-01

    Full Text Available Carcinoma of the follapian tube accounts for only 0.3 to 1.1% of all gynecologic malignancies. Primer carsinoma of follapian tube is a rare and aggressive cancer. It is not diagnosed until at an advanced stage. Because its epidemiologic, biologic and prognostic characteristics arent well known, no standart treatment has been developed. Most of them are adenocarcinomas. Stage is significant prognostic factor. Typical clinical symptoms are vaginal bleeding, watery discharge and pelvic pain. Tubal carsinomas are treated with surgical and chemotherapeutic approach as epithelial ovarian cancer. We reported a 76 year-old woman with primer fallopian tube carcinomas. The case presented with postmenopausal vaginal bleeding. Endometrial curettage showed no abnormal findings. However, we performed laparotomy because of ongoing vaginal bleeding after currettage and left adnexal mass. In the laparotomy, left tube was observed hydropic. The histopathologic result of the left tube revealed primer fallopian tube adenocarcinoma. We performed hysterectomy and bilateral salpingo-oophorectomy. She has been given chemotherapy (endoxan-carboplatin treatment for 4 mounths.

  7. Peri - and Intraocular Mutilating Advanced Squamous Cell Carcinoma: ʺMonsters Inside Your Bodyʺ?

    Directory of Open Access Journals (Sweden)

    Georgi Tchernev

    2018-01-01

    Full Text Available Periocular malignancies represent between 5% and 10% of all types of skin cancers. The incidence of eyelid (but also the periocular located malignancies seems to differ in distribution across the continents.  The incidence of eyelid tumours (but also the periocular located tumours in a predominantly white population determined that BCC is the most common malignant periocular eyelid tumour in whites. This finding has been replicated consistently throughout the literature, with BCC representing 85–95% of all eyelid malignancies, SCC representing 3.4 - 12.6%, Seb Ca representing 0.6 - 10.2%, and both melanoma and Merkel cell carcinoma representing less than 1%. Most periocular skin cancers are associated with ultraviolet radiation (UVR exposure. Ultraviolet radiation causes local immune suppression, which, coupled with DNA abnormalities in tumour suppressor genes and oncogenes, leads to the development of skin cancers.  We are presenting a 62 - year - old patient with a small nodule about 2 cm away from the lower lid of his left eye. A tumour was surgically treated. Several years later there was a tumour relapse, treated with radiotherapy and subsequent chemotherapy with Endoxan and Cisplatin. After the second relapse, he was treated surgically in general anaesthesia by orbital exenteration, removal of the orbital floor and resection of zygomatic bone and the maxillary sinus. A couple of months later, he developed a tumour relapse in the scars and the area of a primary tumour with tumour progression. A possible therapy with Cetuximab or radiation therapy was discussed as a possible treatment option.

  8. Splenic Trapping of Heat-Treated Erythrocytes in Leukaemia and Allied Conditions

    Energy Technology Data Exchange (ETDEWEB)

    Badrawi, H. S.; Razzak, M. A.; Guirgis, B. [Department of Medicine and Division of Nuclear Medicine, Faculty of Medicine, Cairo University, Cairo, United Arab Republic (Egypt)

    1971-02-15

    In a trial to find whether or not the enlarged spleen plays a role in the production of the form of anaemia commonly encountered in leukaemias and allied conditions, 44 patients suffering from these disease states were studied using {sup 51}Cr-labelled erythrocytes heated at 50 Degree-Sign C for 60 min. Cells altered in this manner have been shown by various workers to be selectively sequestered by the spleen. As a control, the test was performed on 24 normal subjects. In these normals, the disappearance half-time of radioactivity from the circulation (T{sub Vulgar-Fraction-One-Half} amounted to 172 {+-} 69 min (mean {+-} 1 S.D.), the lowest limit being 74 min. Accordingly, patients with less than 74 min were considered to have an abnormally rapid disappearance of heat-treated erythrocytes from the circulation and consequently exaggerated splenic sequestration of these altered cells. Splenic trapping of heat-treated erythrocytes was most marked in acute leukaemia (four out of six patients). However, three had associated normoblastic hypoplasia of the sternal marrow. Corticosteroids induced a remission with reversion of both processes responsible for the anaemia in two out of the four patients. In chronic myeloid leukaemia, exaggerated splenic sequestration of altered cells was seen in four of the 15 cases examined. This condition was of extra-erythrocytic origin, since repetition of the test using normal donor heat-treated erythrocytes did not significantly alter the disappearance half-time. However, there was no correlation between the size of the spleen and its avidity for trapping the altered cells. Follow-up studies showed that therapy caused prolongation of the half-time of heat-treated erythrocytes, the effect being more apparent after corticosteroids than with X-rays or Endoxan, In Hodgkin's disease, increased red cell trapping was observed in two out of the seven patients studied. In contrast, five cases of chronic lymphatic leukaemia, six lymphosarcoma and

  9. On vesical pathophysiology in context of chemoradiotherapy

    International Nuclear Information System (INIS)

    Michailov, M.; Welscher, U.; Neu, E.; Hohlbrugger, G.; Staehler, G.

    2003-01-01

    Functional disturbances of urinary bladder are described (incl. methods) after combined oncotherapy of the urogenital system: Radiocystitis (bladder hypertone, incontinence), etc. Earlier and recent results are given. Human detrusor (surgical tissue: 10-30 Gy/min) is over 10-times more radiosensitive than this of animal (rat, guinea pig = GP) and reacted with a dose-dependent tonic contraction (% init. prep. length): After 1 Gy: 4.3±9%; 2.5: 7.8±1.7; 5: 15.9±14.7; 10: 38.2±22.6; 30: 47.4±12.8 (p<0.01 or <0.05 for total n=45). The spontaneous phasic contr. (SPS) disappeared after irradiation in human, but not in GP detrusor preparations. Cytostatics such as cis-platinum (10 ng-1 μg/ml) and endoxan (0.1 ng-100 μg/ml) had inhibitory effects on SPS and contr. after neurogenic electrostimulation of GP (more than 50%), but adriblastin (0.1-10 μg/ml) and colchicine (1-100 μg/ml) - augmentory ones. Electrophysiological data demonstrated the presence of stretch dependent ion channels in GP vesical myocytes: The usual spike activity was transformed into a burst-plateau one: rate of rise and of fall of action potentials increased after stretch (3 to 80 mN: 0.4±0.2 to 3.3±0.7 V/cm resp. 0.4±0.3 to 2.3±0.6, n=33). A probable pathogenetic relation of cytostatic and radiation (acute and late) effects to the described stretch channels and electrical patterns, fast detrusor (1-5/min) and slow trigonal contr. (0.1-0.5/ min) as well as decrease of membrane potential of urothel at radiocystitis is of high scientific interest and has to be investigated: This could open a new possibility for vesical prophylaxis and pharmacotherapy

  10. Thymoma - prognostic factors and treatment results

    International Nuclear Information System (INIS)

    Gripp, S.; Hilgers, K.; Schmitt, G.

    1997-01-01

    Purpose/Objective: To assess the prognostic factors and treatment results of thymoma with emphasis on surgery and radiotherapy. Materials and Methods: Thymoma patients treated at Duesseldorf University Hospital from 1954 to 1991 were studied in this retrospective analysis. Depending on stage and residual disease, treatment was surgery (sternotomy or thoracotomy) with and without radiotherapy and chemotherapy (Holoxan, Endoxan, Vinblastin, Adriamycin, Bleomycin, CDDP, Vepesid). 70 patients (38f, 32m) were enrolled in this study. The mean age was 46,5 years. At presentation the median Karnofsky's index was 90%. In 19% thymoma was accidentally diagnosed, 81% presented symptoms at diagnosis. Masaoka's staging system was used (I: intact capsule; II: invasion of the capsule; III: invasion of neighboring organs; IV: dissemination). Stage at presentation was I:21%; II: 26%; III: 43%; IV: 10%. All histologic slices were peer reviewed. Histologic classification according to Lewis (predominantly lymphocytic: 36%; predominantly epithelial: 23%; mixed type: 33%, spindle cell thymoma: 9%) was applied. All available paraffin embedded specimens (36) were studied with DNA cytometric analysis after Feulgen staining. Occasionally thymoma was accompanied by Myasthenia gravis (23%) or other paraneoplastic syndromes (19%). Statistical analysis was performed using the Kaplan-Meier method and logrank-tests. Multivariate analysis was also performed. Results: From 70 patients treated surgically, 68% were radically resected (R0), 26% incompletely resected (R1,2) and 6% had biopsy only. The median cause specific survival (CSS) was 132 months. All patients with localized disease (stage I and II) were completely resected and received no further therapy, whereas only 50% (15 pat) in stage III and 0% in stage IV were amenable to radical resection. 36% (25 pat) received an additional therapy (CMT): 31% (22 pat) postoperative irradiation and 4% (3 pat) combined radio-chemotherapy. The radiation

  11. Rhabdomyosarcoma: The Experience of the Pediatric Unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001)

    International Nuclear Information System (INIS)

    Abdel Aal, H.H.; Habib, E.E.; Mishrif, M.M.

    2006-01-01

    Our present study is a retrospective analysis of the treatment results of new rhabdomyosarcoma pediatric patients who had attended the pediatric unit clinic of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) from January 1992 to January 200 I). Patients and Methods: Fifty-five new cases of pediatric rhabdomyosarcoma attended the pediatric unit outpatient clinic of (NEMROCK) from the period of January 1992 until January 200 I. Patients were divided into 4 stages and classified into low-risk patients and high-risk patients according to the extent of resection. Stage I, II orbital and stage I para-testicular embryonal rhabdomyosarcomas received 32 weeks of vincristine and actinomycin-D (vincristine 1.5 mg/m 2 weekly, actinomycin-D 0.015 mg/ Kg/day day 1 to day 5). Other pathologies, sites and stages received 52 weeks of chemotherapy. Chemotherapy regimens included VAC (vincristine 1.5 mg/m 2 weekly, actinomycin-D 0.015 mg/Kg/day day 1 to day 5 and endoxan 2.2 gm/m 2 LV with mesna every 21 days), VAl (vincristine, actinomycin-D and ifosfamide 1.8 gm/m2 l.V day 1 to day 5 with mesna) or VIE (vincristine, ifosfamide and vepesid 100 mg/m 2 1. V day 1 to day 5) [11,12]. Stages I and II received conventional fractionation radiotherapy 4140 c Gy on week 13, stages Ill and IV received conventional fractionation radiation therapy 5040 c Gy also, on week 13. The radiation volume included the tumor bed with a 2 cm safety margin at least. Relapsing cases received palliative radiation therapy and chemotherapy (cisplatinum LV 100 mg/m 2 divided over 2 days and vepesid 100 mg/m2 l.V day 1 to day 3 to be recycled every 21 days). Patients were followed-up for 5 years, with a median follow-up of 36 months. Overall survival, disease free survival, treatment response, and complications of treatment were assessed and statistically analyzed. Results: Fifty-five new cases of pediatric rhabdomy-osarcoma attended the pediatric unit outpatient clinic of (NEMROCK) and